SEC Form 4 · accession 0001140361-16-083103
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Oct 18, 2016
Accepted (ET)
Oct 19, 2016 · 8:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Oct 18, 2016 | S | 1,967 | $64.71 | D | 45,513 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule10b5-1 Plan.